MDLZ Margin Recovery Positive but Volume Resilience Unproven

What happened

Mondelez's Q3 2026 results, highlighted by a Seeking Alpha article, showed organic net revenue growth of 2.1%, adjusted gross profit up 14%, and significant margin expansion, which the author attributes to global diversification and strategic moves like the upcoming Oreo refresh and Undercover Snacks acquisition. This comes after a difficult 2025 in which record cocoa costs and broad input inflation drove gross margin down sharply and global volumes declined, as detailed in our prior report. The recent margin recovery is encouraging, but the organic growth rate of 2.1% is notably below the 4%+ seen in 2025, suggesting pricing still dominates and volume/mix may remain weak. The article's bullish tone overlooks persistent risks from tariffs, consumer down-trading, and elevated elasticity that were central to our cautious stance. While the Q3 data points to stabilization, we await further evidence that volume declines have reversed and that cost relief is translating into sustainable EPS growth before upgrading the stock.

Implication

If Mondelez can build on this margin recovery with sustained volume growth and deliver high-single-digit EPS growth with gross margin above 35% in 2026-2027, the thesis would shift to Buy; until then, maintain a Wait stance with an attractive entry near $47.

Thesis delta

The new Q3 2026 results indicate margin recovery and progress on strategic initiatives, which modestly improves the operating outlook. However, organic revenue growth of 2.1% is below the prior year's pace, and volume resilience remains unproven. Our thesis shifts from a neutral Wait to a Wait with a positive bias, but we still require evidence of volume stabilization and EPS acceleration before turning bullish.